| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,187 |
17,348 |
$1.10M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,364 |
6,128 |
$597K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,737 |
12,030 |
$473K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,102 |
4,102 |
$341K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,032 |
4,031 |
$337K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,237 |
3,236 |
$294K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,085 |
3,062 |
$241K |
| 92588 |
|
3,694 |
3,694 |
$184K |
| 90461 |
|
4,488 |
4,448 |
$152K |
| 99215 |
Prolong outpt/office vis |
1,196 |
1,184 |
$138K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
14,047 |
14,029 |
$127K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,222 |
9,046 |
$95K |
| 96127 |
|
6,465 |
6,388 |
$66K |
| 99173 |
|
2,879 |
2,878 |
$63K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,806 |
7,743 |
$59K |
| 95930 |
|
489 |
489 |
$53K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
463 |
463 |
$43K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,349 |
3,257 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,344 |
1,332 |
$39K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,344 |
1,332 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,104 |
1,095 |
$37K |
| 83655 |
|
2,620 |
2,620 |
$31K |
| 86003 |
|
244 |
239 |
$26K |
| 87081 |
|
2,610 |
2,551 |
$17K |
| 94010 |
|
538 |
533 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,213 |
1,068 |
$15K |
| 82465 |
|
3,394 |
3,394 |
$15K |
| 99188 |
|
561 |
561 |
$15K |
| 0071A |
|
167 |
167 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
275 |
275 |
$6K |
| 0072A |
|
122 |
122 |
$6K |
| 81002 |
|
1,722 |
1,644 |
$4K |
| 0001A |
|
91 |
91 |
$4K |
| 82947 |
|
1,019 |
1,000 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
447 |
434 |
$4K |
| 81025 |
|
542 |
535 |
$4K |
| 99050 |
|
205 |
204 |
$3K |
| 92555 |
|
163 |
163 |
$3K |
| 0002A |
|
56 |
56 |
$3K |
| 99383 |
|
14 |
14 |
$1K |
| 87070 |
|
92 |
90 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
64 |
64 |
$991.90 |
| 93000 |
|
43 |
43 |
$580.93 |
| 96161 |
|
68 |
68 |
$262.48 |
| 87807 |
|
21 |
21 |
$248.01 |
| 94760 |
|
13 |
13 |
$32.89 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
25 |
25 |
$32.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
26 |
26 |
$8.90 |